small sized icon representing the Cardiovascular area of interest
Cardiorenal
small sized icon representing the Hematology area of interest
Hematología
small sized icon representing the Ophthalmology area of interest
Oftalmología
small sized icon representing the Oncology area of interest
Oncología
small sized icon representing the Women's Health area of interest
Salud de la Mujer
SPACETu portal médico
OS and AEs with darolutamide vs apalutamide vs enzalutamide
Ir al contenido
Oncología

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castrationresistant prostate cancer: a systematic review and network meta-analysis

Wenzel, M., Nocera, L., Collà Ruvolo, C, et al. Prostate cancer and prostatic diseases, 10.1038/s41391-021-00395-4.

Related Content
Treating the patient and not just the cancer
Cáncer de próstata
Comparison of darolutamide vs apalutamide and enzalutamide
CPRCnm
Darolutamide and health-related QoL in ARAMIS
CPRCnm